The National Times - Trump says 'time running out' as Iran rejects talks amid 'threats'

Trump says 'time running out' as Iran rejects talks amid 'threats'


Trump says 'time running out' as Iran rejects talks amid 'threats'
Trump says 'time running out' as Iran rejects talks amid 'threats' / Photo: © AFP

President Donald Trump on Wednesday warned Iran that time was running out for the Islamic republic to prevent American military intervention as Tehran rejected holding negotiations against a backdrop of threats.

Change text size:

Trump has never ruled out a new attack on Iran in the wake of its deadly crackdown on protests this month, to follow the 12-day June war between the Islamic republic and Israel which the US backed and joined.

A US naval strike group that Trump described as an "armada" led by aircraft carrier the USS Abraham Lincoln is now lurking in Middle East waters.

A rights group said that it has verified over 6,200 deaths, mostly of protesters killed by security forces, in the wave of demonstrations that rocked the clerical leadership since late December but peaked on January 8-9.

Activists say that the actual toll could be many times higher, with an internet shutdown still complicating efforts to confirm information about the scale of the killings.

In his latest post on Truth Social, Trump did not mention the protests but said Iran needed to negotiate a deal over its nuclear programme, which the West believes is aimed at making an atomic bomb.

"Hopefully Iran will quickly 'Come to the Table' and negotiate a fair and equitable deal - NO NUCLEAR WEAPONS -- one that is good for all parties. Time is running out, it is truly of the essence!" said Trump.

Referring to American strikes against Iranian nuclear targets during the June war which he said resulted in "major destruction of Iran", he added: "The next attack will be far worse! Don't make that happen again".

Analysts say options include strikes on military facilities or targeted hits against the leadership under Ayatollah Ali Khamenei, in a full-scale bid to bring down the system that has ruled Iran since the 1979 Islamic revolution that ousted the shah.

- 'Severe damage' -

But Foreign Minister Abbas Araghchi said before Trump's comments were published that "conducting diplomacy through military threat cannot be effective or useful".

"If they want negotiations to take shape, they must certainly set aside threats, excessive demands and raising illogical issues," he said in televised comments.

Araghchi said he had "no contact" with US Middle East envoy Steve Witkoff in recent days and that "Iran has not sought negotiations".

Iranian armed forces chief of staff Habibollah Sayyari warned the US against any "miscalculation", saying that "they too would suffer damage".

New billboards have meanwhile appeared in Tehran, including one showing Iran striking an American aircraft carrier, according to AFP journalists.

- 'Ease tensions' -

Following a call on Tuesday between Iranian President Masoud Pezeshkian and de facto Saudi leader Crown Prince Mohammed bin Salman, Iran reached out to other US allies in the region, in an apparent bid to rally support.

The Secretary of Iran's Supreme National Security Council Ali Larijani spoke with Qatari Prime Minister Sheikh Mohammed bin Abdulrahman Al Thani, who is also foreign minister, both sides said.

Sheikh Mohammed emphasised Qatar's support for "all efforts aimed at reducing escalation and achieving peaceful solutions", the Qatari foreign ministry said.

Egyptian Foreign Minister Badr Abdelatty meanwhile held separate calls with both Araghchi and Witkoff, Cairo said.

Abdelatty stressed the need to intensify efforts to "ease tensions and work towards deescalation" and create the "necessary conditions to resume dialogue between the US and Iran", the Egyptian foreign ministry said.

Turkey's Foreign Minister Hakan Fidan told Al-Jazeera television that "it's wrong to attack Iran. It's wrong to start the war again". He called on Washington to reopen talks on the nuclear standoff.

- 'New dimensions of crackdown' -

In an updated toll, the US-based Human Rights Activists News Agency (HRANA) said it had confirmed that 6,221 people had been killed, including 5,856 protesters, 100 minors, 214 members of the security forces and 49 bystanders.

But the group added it was still investigating another 17,091 possible fatalities. At least 42,324 people have been arrested, it said.

HRANA warned that security forces were searching hospitals for wounded protesters, saying this highlighted "new dimensions of the continued security crackdown".

HRANA said that a trial in Malard outside Tehran on Tuesday of a man accused over the death of a police officer was the first such hearing linked to the protests. Images of the hearing were broadcast on state television in Iran.

It was a "starting point for a broad series of trials" that would be "aimed at imposing severe penalties on protesters", HRANA said.

Meanwhile, Iran on Wednesday executed a man arrested in April 2025 on charges of spying for Israel's Mossad spy agency, the judiciary said. Rights groups fear some protesters could also face the death penalty.

R.Evans--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: